Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer

被引：71

作者：

Moreira, Leticia ^{[1
,2
,3
]}

Bakir, Basil ^{[1
,2
]}

Chatterji, Priya ^{[1
,2
]}

Dantes, Zahra ^{[4
]}

Reichert, Maximilian ^{[4
]}

Rustgi, Anil K. ^{[1
,2
]}

机构：

[1] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Dept Genet, Div Gastroenterol, Philadelphia, PA 19104 USA

[3] Univ Barcelona, IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Hosp Clin,Dept Gastroenterol, Catalonia, Spain

[4] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany

来源：

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 5卷 / 03期

关键词：

3D Organoids; Pancreas; Adenocarcinoma; Personalized Medicine; ESOPHAGEAL EPITHELIAL-CELLS; STEM-CELLS; DUCTAL ADENOCARCINOMA; IN-VITRO; ONCOGENIC KRAS; DRUG RESPONSE; ADULT LIVER; MOUSE; CULTURE; SPHEROIDS;

D O I：

10.1016/j.jcmgh.2017.12.004

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pancreatic ductal adenocarcinoma is one of the most aggressive forms of cancer, and the third leading cause of cancer-related mortality in the United States. Although important advances have been made in the last decade, the mortality rate of pancreatic ductal adenocarcinoma has not changed appreciably. This review summarizes a rapidly emerging model of pancreatic cancer research, focusing on 3-dimensional organoids as a powerful tool for several applications, but above all, representing a step toward personalized medicine.

引用

页码：289 / 298

页数：10

共 50 条

[41] Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
Regel, Ivonne
Mayerle, Julia
Mukund, Mahajan Ujjwal
CANCERS, 2020, 12 (04)
[42] MicroRNAs and Pancreatic Cancer: Current Research and Future Outlooks
Li, Wei
Satoh, Kei
LeBrun, Drake G.
Li, Min
CURRENT SIGNAL TRANSDUCTION THERAPY, 2012, 7 (03) : 305 - 307
[43] A High-Throughput Platform for Culture and 3D Imaging of Organoids
Grenci, Gianluca
Dilasser, Florian
Raffi, Saburnisha Binte Mohamad
Marchand, Marion
Suryana, Mona
Sahni, Geetika
Viasnoff, Virgile
Beghin, Anne
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2022, (188):
[44] 3D Printed Personalized Medicine for Cancer: Applications for Betterment of Diagnosis, Prognosis and Treatment
Harshada Bhuskute
Pravin Shende
Bala Prabhakar
AAPS PharmSciTech, 23
[45] 3D Printed Personalized Medicine for Cancer: Applications for Betterment of Diagnosis, Prognosis and Treatment
Bhuskute, Harshada
Shende, Pravin
Prabhakar, Bala
AAPS PHARMSCITECH, 2021, 23 (01)
[46] Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
Qu, Shanqiang
Xu, Rongyang
Yi, Guozhong
Li, Zhiyong
Zhang, Huayang
Qi, Songtao
Huang, Guanglong
MOLECULAR BIOMEDICINE, 2024, 5 (01):
[47] Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
Shanqiang Qu
Rongyang Xu
Guozhong Yi
Zhiyong Li
Huayang Zhang
Songtao Qi
Guanglong Huang
Molecular Biomedicine, 5
[48] A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine
Simon Plummer
Stephanie Wallace
Graeme Ball
Roslyn Lloyd
Paula Schiapparelli
Alfredo Quiñones-Hinojosa
Thomas Hartung
David Pamies
Scientific Reports, 9
[49] A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine
Plummer, Simon
Wallace, Stephanie
Ball, Graeme
Lloyd, Roslyn
Schiapparelli, Paula
Quinones-Hinojosa, Alfredo
Hartung, Thomas
Pamies, David
SCIENTIFIC REPORTS, 2019, 9 (1)
[50] Updates and current challenges in microRNA research for personalized medicine in ovarian cancer
Mandilaras, Victoria
Vernon, Megane
Meryet-Figuiere, Matthieu
Karakasis, Katherine
Lambert, Bernard
Poulain, Laurent
Oza, Amit
Denoyelle, Christophe
Lheureux, Stephanie
EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (08) : 927 - 943

← 1 2 3 4 5 →